Advice

following an abbreviated submission:

calcium carbonate and cholecalciferol (Kalcipos-D®) is accepted for use within NHS Scotland.

Indications under review:

  • Prevention and treatment of calcium and vitamin D deficiency in the elderly.
  • Vitamin D and calcium supplement in addition to specific osteoporosis treatment of patients who are at risk of vitamin D and calcium deficiency.


This is a new combination product with a different ratio of calcium to cholecalciferol than alternative combination preparations. It is a similar price to an alternative product containing 800IU of cholecalciferol per tablet but is more expensive than some other calcium and cholecalciferol combinations. Any overall budget impact is likely to be small.

Download detailed advice51KB (PDF)

Download

Medicine details

Medicine name:
calcium carbonate + cholecalciferol (Kalcipos-D®)
SMC ID:
718/11
Indication:
Prevention and treatment of calcium and vitamin D deficiency in the elderly
Pharmaceutical company
Meda Pharmaceuticals Ltd
BNF chapter
Nutrition and blood
Submission type
Abbreviated
Status
Accepted
Date advice published
08 August 2011